Company intelligence / Profile preview

Rialto Venture Capital

Ownership: Private
Employees: ~7
Development stage: Other

Overview

Rialto Venture Capital is an Italian venture capital firm focused on supporting European founders in hard tech sectors including B2B software, robotics, non-generative AI, cybersecurity, AR/VR, Enterprise SaaS, tech-enabled healthcare and medtech. Its first fund ("Rialto 1") has raised over €55 million as of mid-2024 and has made eight investments across these verticals. The fund targets Series A stage companies with potential for industrial-scale digital transformation. Portfolio includes healthtech and medtech startups such as Medicilio but the firm itself does not develop therapeutics or devices.

Industry: Investors

Beyond the preview

Go deeper on Rialto Venture Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Rialto Venture Capital.

Explore the full profile